George Robinson, founding partner of emerging markets specialist Sloane Robinson, talks about why he tends to 'ignore' 80% of the market in emerging countries and how his investments in specialist biotech and healthcare university start-ups via his EIS fund have helped him refine his investment style
There can be no doubting George Robinson's appetite for putting money into the cutting edge of investment. After spending the early years of his career working in Asia, he returned to the UK to unite with Hugh Sloane to launch one of the UK's pioneering emerging markets fund groups in 1993 - Sloane Robinson. Since 2004 he has also run the company's emerging markets long/short equity fund. While Sloane Robinson is his day job, Robinson has also forged a reputation as one of the foremost investors in university spin-outs. He runs Oxford Investment Consultants, which advises the inves...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes